| PERIOD ENDING | 30-Sep-09 | 31-Jul-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 103,079 | 99,697 | 99,697 | 96,616 | | Cost of Revenue | 80,590 | 79,618 | 4,247 | 77,855 | | | Gross Profit | 22,489 | 20,079 | 95,450 | 18,761 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,812 | 10,383 | 77,496 | 11,772 | | Non Recurring |
-
|
-
|
-
| 7,157 | | Others | 5,005 | 4,824 | 4,824 | 4,858 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,672 | 4,872 | 4,872 | (5,026) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | 20 | 20 | (22) | | Earnings Before Interest And Taxes | 6,724 | 4,892 | 4,892 | (5,048) | | Interest Expense | 178 | 150 | 150 | 141 | | Income Before Tax | 6,546 | 4,742 | 4,742 | (5,189) | | Income Tax Expense | 2,767 | 1,899 | 1,899 | (2,085) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,779 | 2,843 | 2,843 | (3,104) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,779 | 2,843 | 2,843 | (3,104) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,779 | $2,843 | $2,843 | ($3,104) |
|
0.31% Nasdaq 
0.05%
Income Statement
